Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.

BACKGROUND Metastasis is a process by which tumors spread from primary organs to other sites in the body and is the major cause of death for cancer patients. The ovarian cancer G protein-coupled receptor 1 (OGR1) gene has been shown to be expressed at lower levels in metastatic compared with primary prostate cancer tissues. METHODS We used an orthotopic mouse metastasis model, in which we injected PC3 metastatic human prostate cancer cells stably transfected with empty vector (vector-PC3) or OGR1-expressing vector (OGR1-PC3) into the prostate lobes of athymic or NOD/SCID mice (n = 3-8 mice per group). Migration of PC3 cells transiently transfected with vector control or with OGR1- or GPR4 (a G protein-coupled receptor with the highest homology to OGR1)-expressing vectors was measured in vitro by Boyden chamber assays. G protein alpha-inhibitory subunit 1 (G alpha(i1)) expression after treatment with pertussis toxin (PTX) was measured using immunoblotting analysis. The inhibitory factor present in the conditioned medium was extracted using organic solvents and analyzed by mass spectrometry. RESULTS In vivo, all 26 mice carrying tumors that were derived from vector-PC3 cells developed prostate cancer metastases (mean = 100%, 95% confidence interval [CI] = 83.97% to 100%) but few (4 of 32) mice carrying tumors derived from OGR1-expressing PC3 cells (mean = 12.50%, 95% CI = 4.08% to 29.93%) developed metastases. However, exogenous OGR1 overexpression had no effect on primary prostate tumor growth in vivo. In vitro, expression of OGR1, but not GPR4, inhibited cell migration (mean percentage of cells migrated, 30.2% versus 100%, difference = 69.8%, 95% CI = 63.0% to 75.9%; P<.001) via increased expression of G alpha(i1) and the secretion of a chloroform/methanol-extractable heat-insensitive factor into the conditioned medium through a PTX-sensitive pathway. CONCLUSION OGR1 is a novel metastasis suppressor gene for prostate cancer. OGR1's constitutive activity via G alpha(i) contributes to its inhibitory effect on cell migration in vitro.

[1]  N. Greenberg,et al.  Models of metastatic prostate cancer: a transgenic perspective , 2003, Prostate Cancer and Prostatic Diseases.

[2]  P. Elson,et al.  Unfolding the pathophysiological role of bioactive lysophospholipids. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.

[3]  N. Sugimoto,et al.  Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor Isoform , 2003, Molecular and Cellular Biology.

[4]  L. Yin,et al.  KiSS1 Suppresses Metastasis in Human Ovarian Cancer via Inhibition of Protein Kinase C Alpha , 2005, Clinical & Experimental Metastasis.

[5]  P. Steeg.  Perspectives on classic article: metastasis suppressor genes. , 2004, Journal of the National Cancer Institute.

[6]  G. Geisslinger,et al.  LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[8]  S. Powers,et al.  G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers , 2004, Oncogene.

[9]  A. Ullrich,et al.  Lysophosphatidic acid‐regulated mitogenic ERK signaling in androgen‐insensitive prostate cancer PC‐3 cells , 2002, International journal of cancer.

[10]  C. Rinker-Schaeffer,et al.  Metastasis-suppressor genes: a review and perspective on an emerging field. , 2000, Journal of the National Cancer Institute.

[11]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[12]  E. Latulippe,et al.  Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. , 2002, Cancer research.

[13]  F. Schröder,et al.  Orthotopic implantation of human prostate cancer cell lines: A clinically relevant animal model for metastatic prostate cancer , 1997, The Prostate.

[14]  Yan Xu,et al.  Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. , 2002, Biochimica et Biophysica Acta.

[15]  M. Murakami,et al.  Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. , 2003, International immunology.

[16]  R. Seifert,et al.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[17]  F. Huang,et al.  Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[18]  O. Witte,et al.  Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4* , 2001, The Journal of Biological Chemistry.

[19]  T. Panetti.  Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. , 2002, Biochimica et biophysica acta.

[20]  M. Birnbaum,et al.  Expression of and Role for Ovarian Cancer G-protein-coupled Receptor 1 (OGR1) during Osteoclastogenesis* , 2006, Journal of Biological Chemistry.

[21]  Romain M. Wolf,et al.  Proton-sensing G-protein-coupled receptors , 2003, Nature.

[22]  N. Sugimoto,et al.  Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells. , 2006, Experimental cell research.

[23]  Yan Xu,et al.  Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. , 2001, Analytical biochemistry.

[24]  Y Chen,et al.  Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI‐MS) Analyses , 2000, Annals of the New York Academy of Sciences.

[25]  P. Steeg,et al.  Metastasis suppressor genes: basic biology and potential clinical use. , 2003, Clinical breast cancer.

[26]  F. Bladou,et al.  A Nod Scid mouse model to study human prostate cancer , 2002, Prostate Cancer and Prostatic Diseases.

[27]  D. Welch,et al.  Metastasis suppressor pathways--an evolving paradigm. , 2003, Cancer letters.

[28]  M. Simoni,et al.  Constitutively active mutations of G protein-coupled receptors: the case of the human luteinizing hormone and follicle-stimulating hormone receptors. , 1999, Archives of medical research.

[29]  Koichi Sato,et al.  Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors. , 2005, Cellular signalling.

[30]  B. O'dowd,et al.  Identification of a Molecular Target of Psychosine and Its Role in Globoid Cell Formation , 2001, The Journal of cell biology.

[31]  Koichi Sato,et al.  Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. , 2005, Journal of Pharmacological Sciences.

[32]  S. Kukreja,et al.  Development of skeletal metastasis by human prostate cancer in athymic nude mice , 1988, Clinical & Experimental Metastasis.

[33]  J. Trapman,et al.  The androgen receptor in prostate cancer. , 1996, Pathology, research and practice.

[34]  O. Witte,et al.  Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Jing Qiao,et al.  GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  G. Casey,et al.  Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14. , 1996, Genomics.

[37]  Richard D. Ye,et al.  The Lysophospholipid Receptor G2A Activates a Specific Combination of G Proteins and Promotes Apoptosis* , 2003, The Journal of Biological Chemistry.

[38]  M. Ishii,et al.  RGS18 Acts as a Negative Regulator of Osteoclastogenesis by Modulating the Acid‐Sensing OGR1/NFAT Signaling Pathway , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  D. Im.  Two ligands for a GPCR, proton vs lysolipid , 2005, Acta Pharmacologica Sinica.

[40]  R. Solano,et al.  LOW EXPRESSION OF Gα PROTEIN SUBUNITS IN HUMAN PROSTATE CANCER , 2001 .

[41]  P. Kue,et al.  Essential role for G proteins in prostate cancer cell growth and signaling. , 2000, The Journal of urology.

[42]  P. Steeg.  Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[43]  Li V. Yang,et al.  T cell chemotaxis to lysophosphatidylcholine through the G2A receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Hill,et al.  Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines , 2004, British Journal of Cancer.

[45]  S. Milstien,et al.  The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner. , 2003, Biochemistry.

[46]  Y. Daaka,et al.  G protein-coupled receptors provide survival signals in prostate cancer. , 2002, Clinical prostate cancer.

[47]  A. Verin,et al.  Differential Regulation of Sphingosine-1-phosphate-and Vegf-induced Endothelial Cell Chemotaxis Involvement of G I ␣ 2 -linked Rho Kinase Activity We Compared Stimulus-coupling Pathways Involved in Bovine Pulmonary Artery (pa) and Lung Microvascular Endothelial Cell Migration Evoked by Sphingosine-1 , 2022 .